<DOC>
	<DOC>NCT00372255</DOC>
	<brief_summary>The study will evaluate the immune response and the tolerability of the influenza vaccine administered in children aged 6-13 years old.</brief_summary>
	<brief_title>Study on the Immunogenicity and Tolerability of Influsplit SSW® 2005/2006 in Children Aged 6 - 13 Years</brief_title>
	<detailed_description />
	<criteria>Healthy children or children with an increased health risk due to an underlying chronic disease—such as chronic airways diseases (including asthma), chronic cardiovascular, hepatic and renal diseases as well as diabetes and other metabolic diseases—aged between 6 and 13 years. All subjects must not have received a prior influenza vaccination. All subjects must not have had a prior influenza disease. Use of any study or unlicensed medications/ vaccine other than the study vaccine within 30 days of the vaccination and/or during the study period. Acute illness at the start of the study. Acute, clinically significant pulmonary, cardiovascular abnormalities or abnormalities of the hepatic or renal function. Known allergic reactions which might be caused by the ingredients of the vaccine. Girls postmenarche: pregnancy or positive pregnancytest Multiple sclerosis or congenital or acquired immunodeficiencies.</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>13 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>